GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (HKSE:02126) » Definitions » 6-1 Month Momentum %

JW (Cayman) Therapeutics Co (HKSE:02126) 6-1 Month Momentum % : -30.08% (As of May. 16, 2024)


View and export this data going back to 2020. Start your Free Trial

What is JW (Cayman) Therapeutics Co 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-16), JW (Cayman) Therapeutics Co's 6-1 Month Momentum % is -30.08%.

The industry rank for JW (Cayman) Therapeutics Co's 6-1 Month Momentum % or its related term are showing as below:

HKSE:02126's 6-1 Month Momentum % is ranked worse than
77.29% of 1528 companies
in the Biotechnology industry
Industry Median: -0.795 vs HKSE:02126: -30.08

Competitive Comparison of JW (Cayman) Therapeutics Co's 6-1 Month Momentum %

For the Biotechnology subindustry, JW (Cayman) Therapeutics Co's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW (Cayman) Therapeutics Co's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JW (Cayman) Therapeutics Co's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where JW (Cayman) Therapeutics Co's 6-1 Month Momentum % falls into.



JW (Cayman) Therapeutics Co  (HKSE:02126) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JW (Cayman) Therapeutics Co  (HKSE:02126) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


JW (Cayman) Therapeutics Co 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


JW (Cayman) Therapeutics Co (HKSE:02126) Business Description

Traded in Other Exchanges
Address
No. 699 Zhong Ke Road, 5F, Building B, Pudong New District, Shanghai, CHN
JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co (HKSE:02126) Headlines

No Headlines